These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM, Azuma T, Hatakeyama M. Oncogene; 2007 Jul 12; 26(32):4617-26. PubMed ID: 17237808 [Abstract] [Full Text] [Related]
5. [Progression and the clinical implications of metaplasia and dysplasia in the stomach]. Sancho Poch FJ. Gastroenterol Hepatol; 1999 May 12; 22(5):238-41. PubMed ID: 10396107 [No Abstract] [Full Text] [Related]
6. Natural history of precursor lesions to gastric carcinoma: growth factors and oncogenes in the metaplasia-dysplasia-carcinoma sequence. Filipe MI. Eur J Cancer Prev; 1994 Dec 12; 3 Suppl 2():19-23. PubMed ID: 7735041 [No Abstract] [Full Text] [Related]
7. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. Busuttil RA, Boussioutas A. J Gastroenterol Hepatol; 2009 Feb 12; 24(2):193-201. PubMed ID: 19215332 [Abstract] [Full Text] [Related]
12. [Value of mucin histochemistry in the normal and pathological digestive tract]. Bogomoletz WV, Filipe MI, Potet F. Gastroenterol Clin Biol; 1984 Apr 15; 8(4):364-72. PubMed ID: 6376261 [No Abstract] [Full Text] [Related]
13. Premalignant lesions of the stomach. Gedigk P, Bechtelsheimer H, Mueller-Wallraf R. Isr J Med Sci; 1979 Apr 15; 15(4):405-9. PubMed ID: 447506 [Abstract] [Full Text] [Related]
14. KRAS mutations predict progression of preneoplastic gastric lesions. Gong C, Mera R, Bravo JC, Ruiz B, Diaz-Escamilla R, Fontham ET, Correa P, Hunt JD. Cancer Epidemiol Biomarkers Prev; 1999 Feb 15; 8(2):167-71. PubMed ID: 10067815 [Abstract] [Full Text] [Related]
15. Pancreatic duodenal homeobox-1 (PDX1) functions as a tumor suppressor in gastric cancer. Ma J, Chen M, Wang J, Xia HH, Zhu S, Liang Y, Gu Q, Qiao L, Dai Y, Zou B, Li Z, Zhang Y, Lan H, Wong BC. Carcinogenesis; 2008 Jul 15; 29(7):1327-33. PubMed ID: 18477649 [Abstract] [Full Text] [Related]
16. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression. Li H, Guo L, Li JW, Liu N, Qi R, Liu J. Int J Oncol; 2000 Nov 15; 17(5):927-32. PubMed ID: 11029494 [Abstract] [Full Text] [Related]
17. Biology of intestinal metaplasia in 2008: more than a simple phenotypic alteration. Gutiérrez-González L, Wright NA. Dig Liver Dis; 2008 Jul 15; 40(7):510-22. PubMed ID: 18400571 [Abstract] [Full Text] [Related]
18. [Gastric dysplasia and carcinoma: analytical morphometry of the nuclear form]. Bufo P, Ricco R, Potente F, Troia M. Boll Soc Ital Biol Sper; 1987 Apr 30; 63(4):341-7. PubMed ID: 3447612 [No Abstract] [Full Text] [Related]
19. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H, Tahara E. J Gastroenterol; 2000 Apr 30; 35 Suppl 12():111-5. PubMed ID: 10779229 [Abstract] [Full Text] [Related]
20. [The EGF receptor and stomach cancer]. Piontek M, Hengels KJ. Z Gastroenterol; 1993 Nov 30; 31 Suppl 5():18-20. PubMed ID: 8197793 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]